title: Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization?
abstract: Liver resection (LR) with negative margins confers survival advantage in many patients with hepatic malignancies. However, an adequate future liver remnant (FLR) is imperative for safe LR. Presently, in patients with an inadequate FLR; the 2 most established clinical techniques performed to induce liver hypertrophy are portal vein embolization (PVE) and portal vein ligation. More recently, it has been observed that patients who undergo treatment via Y90 radioembolization experience hypertrophy of the contra-lateral untreated liver lobe. Based on these observations, several investigators have proposed the potential use of this modality as an alternative technique for increasing the FLR prior to liver resection. Y90 radioembolization induces hypertrophy at a slower rate than PVE but has the added advantage of concomitant local disease control and tumour down-staging.
authors: Jin-Yao Teo, Brian KP Goh, Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital, Singapore 169856, Singapore.
authors: Jin-Yao
authors: JY
authors: Teo
authors: Jin-Yao Teo, Brian KP Goh, Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital, Singapore 169856, Singapore.
authors: Brian K P
authors: BK
authors: Goh
mesh_terms: D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D006498:Hepatectomy / Q000009:adverse effects; D006801:Humans; D008113:Liver Neoplasms / Q000098:blood supply* / Q000473:pathology / Q000628:therapy*; D008115:Liver Regeneration; D020360:Neoadjuvant Therapy / Q000009:adverse effects / Q000379:methods*; D011169:Portal Vein; D019275:Radiopharmaceuticals / Q000008:administration & dosage* / Q000009:adverse effects; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D015021:Yttrium Radioisotopes / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes
keywords: Liver hypertrophy; Portal vein embolization; Radioembolization; Selective internal radiation therapy; Y90